Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 4Small Cell Lung Carcinoma 2Multiple Myeloma 2Hematologic Neoplasms 2Neutropenia 1Lymphoma, Non-Hodgkin 1Advanced Pancreatic Cancer 1

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Advanced Pancreatic Cancer × pegylated granulocyte colony-stimulating factor × Clear all
NCT04239001 2020-01-23

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
20 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡